These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10701984)

  • 1. Isolation and identification of cyclic imide and deamidation products in heat stressed pramlintide injection drug product.
    Hekman CM; DeMond WS; Kelley PJ; Mauch SF; Williams JD
    J Pharm Biomed Anal; 1999 Sep; 20(5):763-72. PubMed ID: 10701984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and identification of peptide degradation products of heat stressed pramlintide injection drug product.
    Hekman C; DeMond W; Dixit T; Mauch S; Nuechterlein M; Stepanenko A; Williams JD; Ye M
    Pharm Res; 1998 Apr; 15(4):650-9. PubMed ID: 9587964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of pramlintide degradation in aqueous solution as a function of temperature and pH.
    Kenley RA; Tracht S; Stepanenko A; Townsend M; L'Italien J
    AAPS PharmSciTech; 2000 Mar; 1(2):E7. PubMed ID: 14727840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of forced degradation behavior of pramlintide acetate by HPLC and LC-MS.
    Yuan Y; Li YB; Tai ZF; Xie YP; Pu XF; Gao J
    J Food Drug Anal; 2018 Jan; 26(1):409-415. PubMed ID: 29389581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orthogonal HPLC methods for quantitating related substances and degradation products of pramlintide.
    Demond W; Kenley RA; Italien JL; Lokensgard D; Weilersbacher G; Herman K
    AAPS PharmSciTech; 2000 Mar; 1(1):E6. PubMed ID: 14727855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pramlintide injection drug product robustness studies.
    Kenley RA; Bancroft F; L'Italien J; Stepanenko A; Townsend M; Dixit T
    AAPS PharmSciTech; 2000 Mar; 1(2):E8. PubMed ID: 14727841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deamidation via cyclic imide in asparaginyl peptides.
    Capasso S; Mazzarella L; Sica F; Zagari A
    Pept Res; 1989; 2(2):195-200. PubMed ID: 2520758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloidogenesis of the amylin analogue pramlintide.
    da Silva DC; Fontes GN; Erthal LC; Lima LM
    Biophys Chem; 2016 Dec; 219():1-8. PubMed ID: 27665170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of a succinimide variant of methionyl human growth hormone.
    Teshima G; Stults JT; Ling V; Canova-Davis E
    J Biol Chem; 1991 Jul; 266(21):13544-7. PubMed ID: 1856190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of aspartic acid and asparagine residues in human growth hormone-releasing factor.
    Bongers J; Heimer EP; Lambros T; Pan YC; Campbell RM; Felix AM
    Int J Pept Protein Res; 1992 Apr; 39(4):364-74. PubMed ID: 1428526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stability and degradation pathway of recombinant human parathyroid hormone: deamidation of asparaginyl residue and peptide bond cleavage at aspartyl and asparaginyl residues.
    Nabuchi Y; Fujiwara E; Kuboniwa H; Asoh Y; Ushio H
    Pharm Res; 1997 Dec; 14(12):1685-90. PubMed ID: 9453054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LC-MS/MS-Based Monitoring of In Vivo Protein Biotransformation: Quantitative Determination of Trastuzumab and Its Deamidation Products in Human Plasma.
    Bults P; Bischoff R; Bakker H; Gietema JA; van de Merbel NC
    Anal Chem; 2016 Feb; 88(3):1871-7. PubMed ID: 26713683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical pathways of peptide degradation. II. Kinetics of deamidation of an asparaginyl residue in a model hexapeptide.
    Patel K; Borchardt RT
    Pharm Res; 1990 Jul; 7(7):703-11. PubMed ID: 2395797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence-specific deamidation: isolation and biochemical characterization of succinimide intermediates of recombinant hirudin.
    Bischoff R; Lepage P; Jaquinod M; Cauet G; Acker-Klein M; Clesse D; Laporte M; Bayol A; Van Dorsselaer A; Roitsch C
    Biochemistry; 1993 Jan; 32(2):725-34. PubMed ID: 8422378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultraviolet-photodiode array and high-performance liquid chromatographic/mass spectrometric studies on forced degradation behavior of glibenclamide and development of a validated stability-indicating method.
    Bansal G; Singh M; Jindal KC; Singh S
    J AOAC Int; 2008; 91(4):709-19. PubMed ID: 18727528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of deamidation and isomerization sites on pharmaceutical recombinant antibody using H(2)(18)O.
    Terashima I; Koga A; Nagai H
    Anal Biochem; 2007 Sep; 368(1):49-60. PubMed ID: 17617368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of a histidine residue on the C-terminal side of an asparaginyl residue on the rate of deamidation using model pentapeptides.
    Goolcharran C; Stauffer LL; Cleland JL; Borchardt RT
    J Pharm Sci; 2000 Jun; 89(6):818-25. PubMed ID: 10824141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modes of Degradation and Impurity Characterization in rhPTH (1-34) during Stability Studies.
    Kothari R; Kumar V; Jena R; Tunga R; Tunga BS
    PDA J Pharm Sci Technol; 2011; 65(4):348-62. PubMed ID: 22293522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of cyclic imide-like structures upon the treatment of calmodulin and a calmodulin peptide with heat.
    Martin BL; Wu D; Tabatabai L; Graves DJ
    Arch Biochem Biophys; 1990 Jan; 276(1):94-101. PubMed ID: 2105083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of deamidation sites in the conserved regions of human immunoglobulin gamma antibodies.
    Chelius D; Rehder DS; Bondarenko PV
    Anal Chem; 2005 Sep; 77(18):6004-11. PubMed ID: 16159134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.